CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals announced today that Company executives will present a corporate overview at the 15th Annual Needham Healthcare Conference. The presentation will take place at 3 p.m. on April 12 at the Westin New York Grand Central Hotel in New York City.
About Syros Pharmaceuticals
Syros Pharmaceuticals is a biopharmaceutical company applying a pioneering approach to discover and develop medicines that control the expression of genes with the aim of treating cancer and other serious diseases. Syros has built a proprietary gene control platform that provides the Company with a unique lens to identify crucial genes that become dysregulated in diseased cells. Syros is leveraging its platform to develop a pipeline of gene control product candidates that it believes will provide a profound and durable benefit for patients. The Company’s scientific founders are world-class leaders in gene control research and translation. Launched by Flagship Ventures and ARCH Venture Partners, Syros Pharmaceuticals is located in Cambridge, Mass.
Source: Syros Pharmaceuticals
Released April 6, 2016